Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sigal Kremer-Tal"'
Autor:
Jacob Pitcovski, Nady Gruzdev, Anna Abzach, Chen Katz, Ran Ben-Adiva, Michal Brand-Shwartz, Itamar Yadid, Einav Ratzon-Ashkenazi, Ken Emquies, Hadasa Israeli, Hadar Haviv, Irena Rapoport, Itai Bloch, Roy Shadmon, Zohar Eitan, Dalia Eliahu, Talia Hilel, Morris Laster, Sigal Kremer-Tal, Tamara Byk-Tennenbaum, Ehud Shahar
Publikováno v:
Vaccine
The rapid spread of the COVID-19 pandemic, with its devastating medical and economic impacts, triggered an unprecedented race toward development of effective vaccines. The commercialized vaccines are parenterally administered, which poses logistic ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd550ed6feea52b8e8804fe652c2856
https://pubmed.ncbi.nlm.nih.gov/35078662
https://pubmed.ncbi.nlm.nih.gov/35078662
Autor:
Analisa DiFeo, Jiayan Shi, Elias Scheer, Romina Bromberg, Jaya Sangodkar, Goutham Narla, Kim McClinch, Raheleh Hatami, John A. Martignetti, Rachel Schwartz, Scott L. Friedman, Sigal Kremer-Tal, Aisha Choudhri, Alex Yui Hui, Wai K. Leung
Publikováno v:
European Journal of Cancer. 45:666-676
Gastric cancer is the second most common cancer and a leading cause of cancer-related death worldwide. The Kruppel-like factor 6 (KLF6) tumour suppressor gene had been previously shown to be inactivated in a number of human cancers through loss of he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447b413988fabf1bb070c1dd2d2ab1e0
https://doi.org/10.1016/j.ejca.2008.11.009
https://doi.org/10.1016/j.ejca.2008.11.009
Autor:
Shen Yao, Kevin Kelley, Mirko Tarocchi, N Matsumoto, Xiao Zhao, Scott L. Friedman, Goutham Narla, Sigal Kremer-Tal
Publikováno v:
Oncogene. 26:4428-4434
Kruppel-like factor (KLF) 6 is a tumor-suppressor gene functionally inactivated by loss of heterozygosity, somatic mutation and/or alternative splicing that generates a dominant-negative splice form, KLF6-SV1. Wild-type KLF6 (wtKLF6) expression is de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dcdae3ac4d745216059dde26834944d
https://doi.org/10.1038/sj.onc.1210223
https://doi.org/10.1038/sj.onc.1210223
Autor:
Michaela S. Banck, Sigal Kremer-Tal, Isabel Fiel, Analisa DiFeo, Swan N. Thung, Yingbei Chen, Eldad Hod, Snorri S. Thorgeirsson, Steven Yea, Myron Schwartz, Scott L. Friedman, Goutham Narla, Vincenzo Mazzaferro, Jordi Bruix, Eran Zimran, Ju Seog Lee, Josep M. Llovet, John A. Martignetti
Publikováno v:
Journal of hepatology. 46(4)
Hepatocellular carcinoma (HCC) has the most rapidly rising cancer incidence in the US and Europe. The KLF6 tumor suppressor is frequently inactivated in HCC by loss-of-heterozygosity (LOH) and/or mutation.Here we have analyzed 33 HBV- and 40 HCV-rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f77df2861b262a37fe50eeb7b53b46
https://pubmed.ncbi.nlm.nih.gov/17313992
https://pubmed.ncbi.nlm.nih.gov/17313992
Autor:
Swan N. Thung, Analisa DiFeo, Scott L. Friedman, Goutham Narla, Helen L. Reeves, Jordi Bruix, Sigal Kremer-Tal, Paulette Bioulac-Sage, Amanda Katz, Myron Schwartz, John A. Martignetti
Publikováno v:
Hepatology (Baltimore, Md.). 40(5)
Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, reflecting incomplete characterization of underlying mechanisms and lack of early detection. Kruppel-like factor 6 (KLF6) is a ubiquitously expressed zinc finger transcripti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50e858fff816092b01458be2d00dff4
https://pubmed.ncbi.nlm.nih.gov/15723306
https://pubmed.ncbi.nlm.nih.gov/15723306